Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Joshua Kuban

Vascular & Interventional Radiology Houston, TX Medical Doctor

NPI 1639310550 CMS profile 1348473

1515 Holcombe Blvd, Houston, TX 77030

Open in the dashboard

General payments

$300,831

334 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$48,255 paid to institutions, not to them · program years 2022–2025

Through program year 2025, Joshua Kuban of Houston, TX is reported in the CMS Open Payments database as having received $300,831 across 334 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $48,255 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $44,457 56
2024 General $102,516 114
2023 General $66,396 85
2022 General $55,571 51
2021 General $24,115 14
2020 General $813 2
2019 General $6,963 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joshua Kuban
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Joshua Kuban were reported at $44,457. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Joshua Kuban Vascular & Interventional Radiology median Middle half National median
2019 $6,963 $422 $125–$1,555 $163
2020 $813 $200 $68–$652 $114
2021 $24,115 $280 $99–$866 $132
2022 $55,571 $433 $137–$1,497 $149
2023 $66,396 $506 $152–$2,019 $160
2024 $102,516 $556 $175–$1,930 $164
2025 $44,457 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $187,892 223 payments
  2. Medical Device Business Services, Inc. $72,313 34 payments
  3. Siemens Medical Solutions USA, Inc. $10,029 6 payments
  4. Ethicon Endo-Surgery Inc. $9,383 6 payments
  5. Biocompatibles UK Ltd $6,409 4 payments
  6. Surefire Medical, Inc. $5,547 3 payments
  7. Sirtex Medical Inc $4,293 4 payments
  8. Argon Medical Devices, Inc. $2,264 6 payments
  9. Ethicon US, LLC $1,486 24 payments
  10. Inari Medical, Inc. $440 10 payments
  11. Other $775 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $133,762 52 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $131,365 43 payments
  3. Travel and Lodging $25,566 69 payments
  4. Food and Beverage $10,138 170 payments
Products named General payments · program years 2019–2025
  1. TheraSphere Y90 Glass Microspheres 10 GBq $66,325 50 payments
  2. Certus 140 $62,196 35 payments
  3. General - Embolics $38,052 38 payments
  4. Neuwave $20,973 28 payments
  5. EMBOLD Fibered $11,346 25 payments
  6. General - Therapies $9,885 7 payments
  7. OBSIDIO $8,117 14 payments
  8. LC BEAD $6,409 4 payments
  9. TRINAV INFUSION SYSTEM $5,547 3 payments
  10. GENERAL IO ABLATION $4,800 1 payment
  11. Other $20,963 77 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for Interventional Radiology: 38

Drug cost

$12,917

Median for Interventional Radiology: $333

Branded share of claims

100%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 12 $12,917

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 70 billing codes

Paid by Medicare

$43,603

Medicare's payments for the services billed

Medicare patients

93

Average age 72

Services billed

448

39 women, 54 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 48%
Cancer 48%
Arthritis 45%
Ischemic heart disease 35%
Chronic kidney disease 34%
Atrial fibrillation 28%
COPD 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

334 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record